SFDA Chief Discusses Investment Opportunities with Representatives of US Medical Companies

Dr. Hisham bin Saad Al-Jadhei, CEO of the Saudi Food and Drug Authority, discussed investment opportunities in the health sector in the Kingdom with a delegation of about 40 representatives of US medical companies in Riyadh.

He reviewed the most important investment areas available in the health sector in the Kingdom, stressing the Authority’s commitment to developing the investment environment and enabling companies specialized in the medical field to grow and expand, in addition to reviewing the regulatory systems and legislation in force in the Kingdom, and mechanisms to support investment in the health sector.

This meeting comes within the framework of the Authority’s efforts to develop international partnerships and enhance investments in the health sector, which contributes to improving the quality of health services and supporting the health transformation process in the Kingdom.